You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
ACE Inhibitor and Angiotensin Receptor-II Antagonist Prescribing and Hospital Admissions with Acute Kidney Injury: A Longitudinal Ecological Study
|
---|---|
Published in |
PLOS ONE, November 2013
|
DOI | 10.1371/journal.pone.0078465 |
Pubmed ID | |
Authors |
Laurie A. Tomlinson, Gary A. Abel, Afzal N. Chaudhry, Charles R. Tomson, Ian B. Wilkinson, Martin O. Roland, Rupert A. Payne |
Abstract |
ACE Inhibitors (ACE-I) and Angiotensin-Receptor Antagonists (ARAs) are commonly prescribed but can cause acute kidney injury (AKI) during intercurrent illness. Rates of hospitalization with AKI are increasing. We aimed to determine whether hospital AKI admission rates are associated with increased ACE-I/ARA prescribing. |
X Demographics
The data shown below were collected from the profiles of 40 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 11 | 28% |
United Kingdom | 5 | 13% |
United States | 4 | 10% |
Switzerland | 1 | 3% |
Italy | 1 | 3% |
Saudi Arabia | 1 | 3% |
Ireland | 1 | 3% |
Unknown | 16 | 40% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 32 | 80% |
Scientists | 6 | 15% |
Practitioners (doctors, other healthcare professionals) | 2 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 65 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 2% |
Ireland | 1 | 2% |
Egypt | 1 | 2% |
Unknown | 62 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 13 | 20% |
Researcher | 9 | 14% |
Student > Ph. D. Student | 7 | 11% |
Student > Bachelor | 6 | 9% |
Student > Postgraduate | 5 | 8% |
Other | 13 | 20% |
Unknown | 12 | 18% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 33 | 51% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 8% |
Nursing and Health Professions | 4 | 6% |
Chemistry | 3 | 5% |
Business, Management and Accounting | 1 | 2% |
Other | 5 | 8% |
Unknown | 14 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 90. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 February 2016.
All research outputs
#446,978
of 24,583,586 outputs
Outputs from PLOS ONE
#6,309
of 212,317 outputs
Outputs of similar age
#3,648
of 221,720 outputs
Outputs of similar age from PLOS ONE
#163
of 5,208 outputs
Altmetric has tracked 24,583,586 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 212,317 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.6. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 221,720 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 5,208 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.